Latest Regulatory Clearance News

Genesis Resources has completed its acquisition of full ownership of the Plavica project in North Macedonia and is advancing environmental studies while preparing for drilling campaigns in Australia’s Northern Territory.

New World Resources has upgraded its Antler Copper Deposit resource to 14.2 million tonnes at 3.8% copper equivalent, secured key permitting milestones, and recommended shareholders accept a $0.067 per share takeover offer from Kinterra Capital.

EMVision Medical Devices has secured ethics approvals for two pivotal clinical studies and received a $400,000 milestone payment, marking significant progress toward commercialising its portable First Responder brain scanner.

Buxton Resources reports significant progress across its exploration portfolio, including earthworks at Centurion, heritage survey completion at Madman, and a major graphite testwork success, while regaining full control of Fraser Range after IGO's exit.

Elanor Investors Group announces a $125 million strategic investment from Rockworth Capital Partners to stabilise its balance sheet and fund growth, including the acquisition of Singapore’s Firmus Capital.

Neurizon Therapeutics has formally responded to the FDA's clinical hold on its lead ALS drug NUZ-001, submitting new animal safety data. The company aims to join the HEALEY ALS Platform Trial by late 2025, pending regulatory approval.

PointsBet has firmly dismissed Betr Entertainment’s unsolicited scrip takeover proposal, endorsing instead MIXI Australia’s superior all-cash offer. The board highlights significant risks and uncertainties tied to Betr’s bid while unanimously recommending shareholders accept MIXI’s $1.20 per share offer.

MAC Copper Limited has scheduled a key court hearing on July 30 to progress Harmony Gold’s recommended acquisition, moving closer to shareholder votes and regulatory approvals.

Insignia Financial has agreed to a $4.80 per share acquisition offer from CC Capital, representing a 56.9% premium over its recent share price. The Board unanimously recommends the scheme, pending regulatory and shareholder approvals.

Sky Network Television is set to acquire Discovery NZ for a nominal $1, instantly boosting its revenue by around NZD 95 million and expanding its digital footprint through the ThreeNow platform.

Brookfield has agreed to acquire ESR's remaining 19.9% stake in Cromwell Property Group, pending regulatory approval, signaling a major consolidation in the Australian real estate sector.

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.